1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopt ed by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999. 160:736–755.
2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007. 357:2153–2165.
3. Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy. 2005. 60:565–582.
4. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet. 2003. 361:1111–1118.
5. Brincker H. Sarcoid reactions and sarcoidosis in Hodgkin's disease and other malignant lymphomata. Br J Cancer. 1972. 26:120–123.
6. Brincker H, Wilbek E. The incidence of malignant tumors in patients with respiratory sarcoidosis. Br J Cancer. 1974. 29:247–251.
7. Brincker H. Sarcoidosis and malignancy. Chest. 1995. 108:1472–1474.
8. Reich JM, Mullooly JP, Johnson RE. Linkage analysis of malignancy-associated sarcoidosis. Chest. 1995. 107:605–613.
9. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med. 1999. 160:1668–1672.
10. Cohen PR, Kurzrock R. Sarcoidosis and malignancy. Clin Dermatol. 2007. 25:326–333.
11. Pandha HS, Griffiths H, Waxman J. Sarcoidosis and cancer. Clin Oncol (R Coll Radiol). 1995. 7:277–278.